ORIGINAL RESEARCH
Published on 25 May 2026
Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor
doi 10.3389/fonc.2026.1775326
- 769 views
3,071
Total downloads
19k
Total views and downloads
ORIGINAL RESEARCH
Published on 25 May 2026
MINI REVIEW
Published on 23 Apr 2026
MINI REVIEW
Published on 20 Apr 2026
ORIGINAL RESEARCH
Published on 20 Apr 2026
ORIGINAL RESEARCH
Published on 09 Mar 2026
ORIGINAL RESEARCH
Published on 04 Mar 2026
REVIEW
Published on 27 Feb 2026
ORIGINAL RESEARCH
Published on 17 Feb 2026
ORIGINAL RESEARCH
Published on 28 Jan 2026
ORIGINAL RESEARCH
Published on 26 Jan 2026
ORIGINAL RESEARCH
Published on 14 Jan 2026
ORIGINAL RESEARCH
Accepted on 04 Jun 2026